COVID Drug 'Virafin' By Zydus To Cost Rs 11,995 Per Dose
Pharmaceutical giant Zydus Cadila has announced that a dose of its COVID-19 drug 'Virafin' will cost Rs 11,995. The company has claimed that Virafin will lessen the need for oxygen in COVID-19 patients. The drug was earlier approved by the Drug Controller General of India on April 23 for treatment of mild COVID-19 cases. Meanwhile, Zydus is also in the process to launch its three-dose COVID-19 vaccine Zy-CoV-D.
Tags: Zydus Cadila, Virafin, Covid-19, Covid Vaccine
Courtesy: India Today
DCGI Nods Emergency Use Of Zydus Cadila's 'Virafin' For Moderate COVID-19
The Drugs Controller General of India on April 23 approved the emergency use of Zydus Cadila's Pegylated Interferon alpha-2b (PegIFN), ‘Virafin' to treat moderately infected COVID patients. Reportedly, Zydus claims that 91.5% of patients administered with this drug have shown fast recovery while requiring less oxygen for treatment. Interestingly, they also tested negative on RT-PCR test by day 7. India recorded 3.32 lakh fresh COVID-19 cases… read-more
Tags: Virafin, DCGI, Covid-19, drug, Indian Pharma
Courtesy: Times Now news